Pathway | Count | p-Value | q-Value | Gene |
---|---|---|---|---|
Oxidative phosphorylation | 24 | 4.93E-28 | 5.32E-26 | Atp5b;Cox4i1;Ndufb5;Cox6c;Cox5a;LOC685596;Cox6c1;Atp5a1;LOC683884;Ndufab1;Cox5b;Cox6b1;RGD1559626;Atp5h;Ndufa5;Uqcrfs1;Ndufb8;Ndufa3;LOC684509;Atp5f1;LOC692052;LOC679739;Uqcrq;Ndufs5 |
Alzheimer's disease | 27 | 2.22E-27 | 1.20E-25 | Atp5b;Cox4i1;Plcb3;Ndufb5;Cox6c;Cox5a;Plcb4;LOC685596;Cox6c1;Atp5a1;LOC683884;Ndufab1;Cox5b;Cox6b1;RGD1559626;Atp5h;Ndufa5;Uqcrfs1;Ndufb8;Ndufa3;LOC684509;Atp5f1;LOC692052;LOC679739;Uqcrq;Ndufs5;Lpl |
Parkinson's disease | 24 | 8.34E-27 | 3.00E-25 | Atp5b;Cox4i1;Ndufb5;Cox6c;Cox5a;LOC685596;Cox6c1;Atp5a1;LOC683884;Ndufab1;Cox5b;Cox6b1;RGD1559626;Atp5h;Ndufa5;Uqcrfs1;Ndufb8;Ndufa3;LOC684509;Atp5f1;LOC692052;LOC679739;Uqcrq;Ndufs5 |
PPAR signaling pathway | 9 | 1.49E-10 | 1.46E-09 | Fabp2;Hmgcs2;Ehhadh;Acadm;Cpt1a;Pdpk1;Cpt2;Lpl;Angptl4 |
Valine, leucine and isoleucine degradation | 7 | 3.94E-09 | 3.54E-08 | Hmgcs2;Ehhadh;Acadm;Acaa2;Pccb;Acaa2;Hadha;Bcat1 |
Fatty acid metabolism | 6 | 7.74E-08 | 5.57E-07 | Ehhadh;Acadm;Acaa2;Cpt1a;Acaa2;Hadha;Cpt2 |
Arginine and proline metabolism | 5 | 7.00E-07 | 4.45E-06 | Ckmt1;Ckb;Eprs;Rars;P4ha3 |
Drug metabolism - other enzymes | 5 | 5.56E-06 | 2.73E-05 | Ugt1a3;Ugt1a6;Ugt1a1;Ces2;Upp1 |
Fatty acid elongation in mitochondria | 3 | 1.69E-05 | 7.95E-05 | Acaa2;Acaa2;Hadha;Ppt1 |
Propanoate metabolism | 4 | 2.12E-05 | 9.55E-05 | Ehhadh;Acadm;Pccb;Hadha |
Drug metabolism - cytochrome P450 | 5 | 2.89E-05 | 1.20E-04 | Ugt1a3;Ugt1a6;Ugt1a1;Gstm5;Fmo1 |